D’Amico prostate-cancer risk classification
D’Amico prostate-cancer risk classification - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the D’Amico prostate-cancer risk classification → Runs in your browser. No signup, no tracking.
What this is
D’Amico prostate-cancer risk classification is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. D’Amico prostate-cancer risk classification - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
D’Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969-974. Read the source ↗
Worked example: Intermediate risk of biochemical recurrence (driven by Gleason; the worst feature governs).
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.